American Heart News - Stroke News
OCTOBER 21, 2024
Guideline Highlights: Each year in the U.S., over half a million people have a first stroke; however, up to 80% of strokes may be preventable. The new primary prevention of stroke guideline from the American Stroke Association urges health care.
HCPLive
OCTOBER 21, 2024
Kidney Compass: Navigating Clinical Trials is a multimedia podcast from HCPLive hosted by Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, aimed at exploring the latest in clinical trials and updates in nephrology.
Dr. Malcolm Kendrick
OCTOBER 21, 2024
21st October 2024 Finally, the dust settles. Zoë and I won our case against the Mail on Sunday. The judgement came out a few weeks ago, but the legal wrangling continued – and still continues. The Mail on Sunday did print an apology. Legally, they do not have to print an apology, but they did, which says something. There is still a statement in open court to come (SIOC).
Cardiovascular Diabetology
OCTOBER 21, 2024
Patients with low-to-normal body mass index (BMI; < 25.0 kg/m2) were underrepresented in major randomized controlled trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes. The present st.
Med Page Today
OCTOBER 21, 2024
(MedPage Today) -- The American Heart Association and the American Stroke Association updated guidelines for the primary prevention of stroke, emphasizing primary care screening, lifestyle management, and risk factor control. The guideline, published.
Science Daily - Heart Disease
OCTOBER 21, 2024
Updated clinical recommendations, including lifestyle changes, prevention strategies and treatment options, to reduce the risk of a first stroke have been outlined in a new guideline.
Cassling
OCTOBER 21, 2024
While you weren’t looking, a lot has been happening in the field of ultrasound! New technologies, new workflows, new best practices. Over just a few short years, the potential uses of ultrasound have grown exponentially, and that means exciting things for you and your imaging team. Join us as we take a look at the latest developments in ultrasound you may have missed, even if you’re working on equipment that’s just a couple years old.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Hypertension Journal
OCTOBER 21, 2024
Hypertension, Ahead of Print. BACKGROUND:Primary aldosteronism (PA) is a common cause of human hypertension. Somatic mutations inKCNJ5,CACNA1D,ATP1A1, andATP2B3are found in at least 80% of aldosterone-producing adenomas, which cause unilateral PA in humans. Somatic mutations have been identified infrequently in 7 other genes; few of these were known to play a role in aldosterone secretion before the discovery of their mutations.
HCPLive
OCTOBER 21, 2024
Pegcetacoplan injection showed increased benefit for subfoveal GA, with as few as 6 injections, over 3 years in the GALE extension trial.
Becker's Hospital Review - Cardiology
OCTOBER 21, 2024
A vascular surgeon at Salt Lake City-based Intermountain Health has become the first in the U.S. to use the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis device for the treatment of an aortic aneurysm outside of a clinical trial.
HCPLive
OCTOBER 21, 2024
In the most recent Lungcast, Rachel Eddy, PhD, joined host Al Rizzo, MD, to speak to listeners about the current and future uses of AI in lung imaging.
Cardiovascular Diabetology
OCTOBER 21, 2024
The therapeutic effects of ertugliflozin, a sodium-glucose cotransporter 2 inhibitor, on cardiovascular outcome are not fully understood. This study aimed to evaluate the efficacy and safety of ertugliflozin o.
HCPLive
OCTOBER 21, 2024
These data suggest more immediate benefits to alitretinoin, though ultraviolet therapy was shown to be cost-effective after 10 years of use.
Cardiovascular Diabetology
OCTOBER 21, 2024
The Steno Type 1 Risk Engine (ST1RE) was developed to aid clinical decisions in primary prevention for individuals with type 1 diabetes (T1D), as existing cardiovascular (CV) risk models for the general popula.
HCPLive
OCTOBER 21, 2024
A study found that adding depression to Life's Essential 8 provides minimal improvements in predicting cardiovascular and all-cause mortality risk.
Journal of Cardiothoracic Surgery
OCTOBER 21, 2024
Double aortic arch (DAA) is a type of vascular ring, causing stridor and dysphagia owing to compression of the trachea and esophagus. In contrast, double innominate veins, which is a relatively rare venous ano.
DAIC
OCTOBER 21, 2024
tim.hodson Mon, 10/21/2024 - 15:52 Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops , a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions. The acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, advancing the personalized treatment of patients with heart diseases.
Open Heart
OCTOBER 21, 2024
Background Patients with heart failure exhibiting low systolic blood pressure (SBP) have a poor prognosis. Sacubitril/valsartan reduces cardiovascular events; however, its use in patients with low SBP has not been fully examined. Therefore, in this study, we aimed to investigate the association between baseline SBP and adverse events (AEs) in patients starting sacubitril/valsartan therapy using data from a real-world registry in Japan.
DAIC
OCTOBER 21, 2024
Boston Scientific has received U.S. FDA approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance for the new FARAVIEW Software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation System. tim.hodson Mon, 10/21/2024 - 11:41 Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S.
International Journal of Cardiovascular Sciences
OCTOBER 21, 2024
On September 21, 2024, during the 79th Brazilian Congress of Cardiology in Brasília, we celebrated excellence in research and publication with the SBC Scientific Publication Award for the Family ABC journals! During this ceremony, we honored the best original articles, the most cited articles, and the most active reviewers of the journals ABC Cardiol, IJCS, ABC Imagem, and ABC HF.
DAIC
OCTOBER 21, 2024
tim.hodson Mon, 10/21/2024 - 11:24 Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm Advocates , a new, shared vision, cause-related nonprofit 501(c)(4) advocacy organization to complement the primary 501(c)(3) nonprofit structure of the HRS. This announcement comes at a time when atrial fibrillation (AF) is on the rise, affecting more than 10.5 million Americans. 1 A growing patient population, increase in electrophysiology pr
HCPLive
OCTOBER 21, 2024
Decreasing Vitamin A dimerization could be a potential mechanism to treat geographic atrophy, according to results from the two-year SAGA study at AAO 2024.
American College of Cardiology
OCTOBER 21, 2024
In this episode, Andrea Price, MS, AACC hosts Lydia Tran, PharmD, BCPS and Sushma Dey, PharmD, BCACP to discuss the role of the pharmacists on the care team for hypertension management.
HCPLive
OCTOBER 21, 2024
Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population.
American College of Cardiology
OCTOBER 21, 2024
Patients with moderate or severe tricuspid regurgitation (TR) prior to undergoing TAVR or mitral transcatheter edge-to-edge repair (TEER), when compared to patients with no or mild TR, were associated with worse health status and clinical outcomes, according to a study published in JACC: Cardiovascular Interventions.
HCPLive
OCTOBER 21, 2024
At AAO 2024, Pearlman discusses how an innovative oral approach may provide an alternative pathway to existing treatments for DME.
American College of Cardiology
OCTOBER 21, 2024
Hypertriglyceridemia (HTG) remains a significant clinical challenge because of its association with increased cardiovascular (CV) risk and acute pancreatitis.
HCPLive
OCTOBER 21, 2024
Medical experts review the data on the use of oral JAK inhibitors for maintenance and rescue treatments in atopic dermatitis.
American College of Cardiology
OCTOBER 21, 2024
The following are key points to remember from a European clinical consensus statement on intra-operative and post-operative management of conduits for coronary artery bypass grafting (CABG).
HCPLive
OCTOBER 21, 2024
Test your knowledge of the 2024 American College of Gastroenterology H. pylori management guidelines with this clinical quiz!
American College of Cardiology
OCTOBER 21, 2024
What is the relationship between non–high-density lipoprotein cholesterol (non–HDL-C) levels after myocardial infarction (MI) and risk of adverse outcomes?
HCPLive
OCTOBER 21, 2024
Endophthalmitis incidence remained similar between face masking and non-face masking groups during anti-VEGF treatment.
American College of Cardiology
OCTOBER 21, 2024
How important is proper arm position in obtaining accurate blood pressure (BP) measurements?
HCPLive
OCTOBER 21, 2024
Medical experts share their final thoughts on the future of atopic dermatitis treatment with oral systemic agents.
Journal of Cardiovascular Pharmacology
OCTOBER 21, 2024
Cardiac hypertrophy is a crucial risk factor for heart failure when the heart is confronted with physiological or pathological stimuli. The ubiquitin-proteasome system (UPS) plays a critical role in the pathogenesis of cardiac hypertrophy. However, as a key component of the UPS, the role of deubiquitinating enzymes (DUBs) in cardiac hypertrophy is not well understood.
HeartRhythm
OCTOBER 21, 2024
The most common masses on pacemaker leads are thrombi and infective endocarditis(1). Neoplasms attached to pacemaker leads are less frequently encountered. The mainstay treatment of infective endocarditis and large masses (particularly those that do not respond to medical therapy) is lead extraction. With large masses a surgical approach is typically pursued(1).
Journal of Cardiovascular Electrophysiology
OCTOBER 21, 2024
Abstract Introduction Catheter ablation for atrial fibrillation (AF) reduces heart failure (HF) hospitalization in patients with HF with preserved ejection fraction (HFpEF). However, the long-term outcomes and subclinical HF after nonparoxysmal AF ablation in HFpEF patients have not been fully evaluated. Methods and Results One-hundred-ninety nonparoxysmal AF patients with left ventricular ejection fraction ≥50% who underwent first-time AF ablation were studied.
Expert insights. Personalized for you.
143 
Let's personalize your content